Dr. Reddy’s Laboratories holds 42nd annual shareholder meeting via videoconference
RDY•Annual general meeting and resolutions
Dr. Reddy’s Laboratories held its 42nd annual general meeting on July 23, 2026.
- Shareholders adopted the audited standalone and consolidated financial statements for the year ended March 31, 2026.
- A final dividend of INR 8 per equity share was declared for the year ended March 31, 2026.
- Investors backed the re-appointment of K Satish Reddy as a director.
- Other resolutions passed included appointing Deloitte Haskins & Sells as statutory auditor, director appointments, and ratification of cost auditor remuneration.
